TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Arthro Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Turnover |
27,059
|
19,468
|
3,852 |
| Financial expenses |
1,188
|
1,087
|
959 |
| Earnings before taxes |
-6,077
|
-6,737
|
-11,769 |
| EBITDA |
-825
|
-1,674
|
-7,801 |
| Total assets |
15,790
|
17,273
|
25,762 |
| Current assets |
6,181
|
5,124
|
8,278 |
| Current liabilities |
4,024
|
6,144
|
2,381 |
| Equity capital |
-9,055
|
-9,442
|
5,454 |
| - share capital |
52
|
44
|
33 |
| Employees (average) |
191
|
157
|
85 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Solvency |
-57.3%
|
-54.7%
|
21.2% |
| Turnover per employee |
142
|
124
|
45 |
| Profit as a percentage of turnover |
-22.5%
|
-34.6%
|
-305.5% |
| Return on assets (ROA) |
-31.0%
|
-32.7%
|
-42.0% |
| Current ratio |
153.6%
|
83.4%
|
347.7% |
| Return on equity (ROE) |
67.1%
|
71.4%
|
-215.8% |
| Change turnover |
8,253
|
15,605
|
-10,568 |
| Change turnover % | 44% | -73% | |
| Chg. No. of employees |
34
|
72
|
5 |
| Chg. No. of employees % | 22% | 6% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.